Dystrophinopathy caused by mid-intronic substitutions activating cryptic exons in the DMD gene

被引:39
作者
Béroud, C
Carrié, A
Beldjord, C
Deburgrave, N
Llense, S
Carelle, N
Peccate, C
Cuisset, JM
Pandit, F
Carré-Pigeon, F
Mayer, M
Bellance, R
Récan, D
Chelly, J
Kaplan, JC
Leturcq, F
机构
[1] Cochin Hosp, Mol Genet Lab, Paris, France
[2] Hop La Pitie Salpetriere, Biochem Lab A, Paris, France
[3] CHRU, Hop Salengro, F-59037 Lille, France
[4] CHU Reims, Reims, France
[5] Hop St Vincent de Paul, F-75674 Paris, France
[6] Hop Meynard, F-97200 Fort De France, France
关键词
dystrophinopathy; mid-intronic substitution; cryptic exons; DMD gene;
D O I
10.1016/S0960-8966(03)00169-X
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In the course of a mutation search performed by muscle dystrophin transcript analysis in 72 Duchenne and Becker Muscular Dystrophies (DMD/BMD) patients without gross gene defect, we encountered four unrelated cases with additional out-of-frame sequences precisely intercalated between two intact exons of the mature muscle dystrophin mRNA. An in silico search of the whole dystrophin genomic sequence revealed that these inserts correspond to cryptic exons flanked by one strong and one weak consensus splice site and located in the mid-part of large introns (introns 60, 9, 1M, and 62, respectively). In each case we identified an intronic point mutation activating the cryptic donor or acceptor splice site. The patients exhibited a BMD/intermediate phenotype consistent with the presence of reduced amounts of normally spliced transcript and normal dystrophin. The frequency of this new type of mutation is not negligible (6% of our series of 65 patients with 'small' mutations). It would be missed if the exploration of the DMD gene is exclusively performed on exons and flanking sequences of genomic DNA. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:10 / 18
页数:9
相关论文
共 42 条
  • [1] Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy
    Aartsma-Rus, A
    Bremmer-Bout, M
    Janson, AAM
    den Dunnen, JT
    van Ommen, GJB
    van Deutekom, JCT
    [J]. NEUROMUSCULAR DISORDERS, 2002, 12 : S71 - S77
  • [2] THE STRUCTURAL AND FUNCTIONAL DIVERSITY OF DYSTROPHIN
    AHN, AH
    KUNKEL, LM
    [J]. NATURE GENETICS, 1993, 3 (04) : 283 - 291
  • [3] Multiplex Western blotting system for the analysis of muscular dystrophy proteins
    Anderson, LVB
    Davison, K
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (04) : 1017 - 1022
  • [4] Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1
    Ars, E
    Serra, E
    García, J
    Kruyer, H
    Gaona, A
    Lázaro, C
    Estivill, X
    [J]. HUMAN MOLECULAR GENETICS, 2000, 9 (02) : 237 - 247
  • [5] Dystrophin muscle enhancer 1 is implicated in the activation of non-muscle isoforms in the skeletal muscle of patients with X-linked dilated cardiomyopathy
    Bastianutto, C
    Bestard, JA
    Lahnakoski, K
    Broere, D
    De Visser, M
    Zaccolo, M
    Pozzan, T
    Ferlini, A
    Muntoni, F
    Patarnello, T
    [J]. HUMAN MOLECULAR GENETICS, 2001, 10 (23) : 2627 - 2635
  • [6] Diagnostic protein expression in human muscle biopsies
    Bornemann, A
    Anderson, LVB
    [J]. BRAIN PATHOLOGY, 2000, 10 (02) : 193 - 214
  • [7] Analysis of canonical and non-canonical splice sites in mammalian genomes
    Burset, M
    Seledtsov, IA
    Solovyev, VV
    [J]. NUCLEIC ACIDS RESEARCH, 2000, 28 (21) : 4364 - 4375
  • [8] Listening to silence and understanding nonsense: Exonic mutations that affect splicing
    Cartegni, L
    Chew, SL
    Krainer, AR
    [J]. NATURE REVIEWS GENETICS, 2002, 3 (04) : 285 - 298
  • [9] CHILLON M, 1995, AM J HUM GENET, V56, P623
  • [10] The regulation of splice-site selection, and its role in human disease
    Cooper, TA
    Mattox, W
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (02) : 259 - 266